Literature DB >> 12832719

Renal haemodynamics and natriuretic responses to intravenous administration of diadenosine tetraphosphate (Ap4A) and nicotinamide adenine dinucleotide (NAD) in rat.

M Szczepańska-Konkel1, G Langner, G Bednarczuk, A Stiepanow-Trzeciak, M Jankowski, S Angielski.   

Abstract

Effects of Ap4A and NAD--precursor of adenosine, on renal plasma flow (RPF), glomerular filtration rate (GFR) and urine excretion were determined in the anaesthetised rats. Infusion of Ap4A or NAD (i.v., bolus--1 micromol/kg followed by 10 nmol/min/kg) decreased RPF and GFR (by 30 and 40%, respectively). In spite of GFR reduction during Ap4A infusion, the significant increase in sodium excretion and urine flow was noticed: fractional sodium (FENa) and urine excretion (FEurine) rose 15-fold and 2.5-fold in comparison with the control value, respectively. In contrast to Ap4A, NAD-induced decrease in GFR was associated with parallel decrease in sodium and urine excretion, thus the FENa and FEurine did not significantly change. Pretreatment with adenosine deaminase (adenosine degrading enzyme, 2 U/min/kg) or theophylline (P1-receptors antagonist, 0.2 mmol/min/kg) ceased responses to NAD, whereas Ap4A-induced changes were not affected. Pre-treatment with suramin (P2-receptors antagonist, (i.v., bolus--12 mg/kg followed by 1.2 mg/min/kg) completely abolished the renal effects of Ap4A. We conclude that Ap4A may exert specific action on renal function. It acts different from NAD that modified renal function through its hydrolysis product--adenosine. Ap4A might reduce glomerular filtration rate and evoke natriuresis and diuresis, and its effects are probably mediated through stimulation of P2-receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832719

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  3 in total

1.  Effects of diadenosine polyphosphates on glomerular volume.

Authors:  Miroslawa Szczepańska-Konkel; Maciej Jankowski; Anna Stiepanow-Trzeciak; Stefan Angielski
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

2.  P2Y₂ receptor activation decreases blood pressure and increases renal Na⁺ excretion.

Authors:  Timo Rieg; Maria Gerasimova; José L Boyer; Paul A Insel; Volker Vallon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-25       Impact factor: 3.619

3.  A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD.

Authors:  Ross Grant; Jade Berg; Richard Mestayer; Nady Braidy; James Bennett; Susan Broom; James Watson
Journal:  Front Aging Neurosci       Date:  2019-09-12       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.